heterocyclic compounds

Preferred Label : heterocyclic compounds;

MeSH definition : Ring compounds having atoms other than carbon in their nuclei. (Grant & Hackh's Chemical Dictionary, 5th ed); Cyclic compounds that include atoms other than carbon in their ring structure.;

MeSH synonym : compounds, heterocyclic; Heterocyclic Compound; Compound, Heterocyclic;

MeSH annotation : GEN or unspecified; prefer specific groups or specific cpd; DF: HETEROCYCLIC CPDS; general or unspecified; prefer specific groups or specific compound;

Wikipedia link : https://en.wikipedia.org/wiki/Heterocyclic compound;

Is substance : O;

Details

Origin ID

D006571;

UMLS CUI

C0019398;

ATC code(s)
- sulfonamides (heterocyclic) [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Heterocyclic compounds [PASCAL theme]
- Heterocyclic compounds [PASCAL theme]
Currated CISMeF NLP mapping
- Heterocyclic Compound [NCIt concept]
- heterocyclic compounds [IUPAC Term]
Metaterm(s)
- chemistry [CISMeF Metaterm]
Record concept(s)
- heterocyclic compounds [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1,4,7-tribenzyl-1,4,7-triazacyclononane-N,N',N'')(methylcyano)copper chlorate [MeSH Supplementary Concept]
- (1,4,7-triisopropyl-1,4,7-triazacyclonanane-N,N',N'')(methylcyano)copper trifluoromethylsulfonate [MeSH Supplementary Concept]
- (1-carboxyethyl-4,7-bis((6-carboxypyridin-2-yl)methyl)-1,4,7-triazacyclononane) [MeSH Supplementary Concept]
- (1-methylphosphonic-acid-4,7-bis((6-carboxypyridin-2-yl)methyl)-1,4,7-triazacyclononane) [MeSH Supplementary Concept]
- (2-(4,7-biscarboxymethyl(1,4,7)triazacyclonona-1-yl-ethyl)carbonylmethylamino)acetic acid [MeSH Supplementary Concept]
- (2-(4,7-biscarboxymethyl(1,4,7)triazacyclononan-1-ylethyl)carbonylmethylamino)acetic acid [MeSH Supplementary Concept]
- (3-(4,7-biscarboxymethyl(1,4,7)triazacyclononan-1-ylpropyl)carbonylmethylamino)acetic acid [MeSH Supplementary Concept]
- (4,7-bis-carboxymethyl-10-(2-aminoethyl)-1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid [MeSH Supplementary Concept]
- (4S,5S)-4,5-dihydroxy-1,2-dithiane [MeSH Supplementary Concept]
- 1,2,4-trioxane [MeSH Supplementary Concept]
- 1,2-dioxetane [MeSH Supplementary Concept]
- 1,3-dithiane [MeSH Supplementary Concept]
- 1,3-dithiolane [MeSH Supplementary Concept]
- 1,4,10,13-tetraoxa-7,16-diaza-cycloctadecane [MeSH Supplementary Concept]
- 1,4,7,10-tetraazacyclododecane-N,N',N''N'''-etraacetic acid-lys(8)-vasotocin [MeSH Supplementary Concept]
- 1,4,7-triazacyclononane [MeSH Supplementary Concept]
- 1,4,7-triazacyclononane-1,4,7-tris-(glutaric acid) [MeSH Supplementary Concept]
- 1,4,7-triazacyclononane-1,4-diacetate [MeSH Supplementary Concept]
- 1,4,7-triazacyclononane-N,N',N''-triacetic acid [MeSH Supplementary Concept]
- 1,4-dithiane [MeSH Supplementary Concept]
- 1,5-dioxaspiro(3.2)hexane [MeSH Supplementary Concept]
- 1,5-dioxepan-2-one [MeSH Supplementary Concept]
- 1,7-dimethyl-1,4,7,10-tetraazacyclododecane [MeSH Supplementary Concept]
- 1-(2-guanidinoethyl)-4-(2-hydroxyethyl)-1,4,7-triazacyclononane hydrochloride [MeSH Supplementary Concept]
- 1-(2-hydroxyphenyl)-2-(2-pyridylmethyl)-4-(hydroxyimino)-2-azapentane [MeSH Supplementary Concept]
- 1-(3-aminopropyl)-4-methyl-1,4,8,11-tetraazacyclotetradecane [MeSH Supplementary Concept]
- 1-(4-fluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)cinnoline-3-carboxylic acid [MeSH Supplementary Concept]
- 1-(phenylmethyl)-4,7,10-tris((4'-methylphenyl)sulfonyl)-1,4,7,10-tetraazacyclododecane [MeSH Supplementary Concept]
- 1-acetato-1,4,7-triazacyclononane [MeSH Supplementary Concept]
- 1-ethylphenoxathiin 10,10-dioxide [MeSH Supplementary Concept]
- 1-methyl-2-thietaniumcarboxylic acid [MeSH Supplementary Concept]
- 12(4-nitrobenzyl)-1,4,7,10-tetraazacyclotridecane-1,4,7-triacetic acid [MeSH Supplementary Concept]
- 12-(4-nitrobenzyl)-1,4,7,10-tetraazacyclotridecane-1,4,7,10-tetraacetic acid [MeSH Supplementary Concept]
- 2,2-dichloro-1,3-dithiacyclobutanone [MeSH Supplementary Concept]
- 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaaza-isowurtzitane [MeSH Supplementary Concept]
- 2,4,6-triphenylverdazyl [MeSH Supplementary Concept]
- 2,5-dihydroxy-1,4-dithiane [MeSH Supplementary Concept]
- 2,6-epoxyazocane [MeSH Supplementary Concept]
- 2-(4-isothiocyanatobenzyl)-1,4,7,10--tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)cyclododecane [MeSH Supplementary Concept]
- 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid [MeSH Supplementary Concept]
- 2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid [MeSH Supplementary Concept]
- 2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- 2-vinyl-4H-1,3-dithiin [MeSH Supplementary Concept]
- 3,3'-(1,2,4,5-tetrazine-3,6-diyl)dibenzoic acid [MeSH Supplementary Concept]
- 3,4-9,10-13,14-tribenzo-1,12-diaza-5,8-dioxacyclotetradecane-1,11-diene [MeSH Supplementary Concept]
- 3,7-bis(3-trifluoromethylphenyl)-1,5,3,7-dioxadiazocane [MeSH Supplementary Concept]
- 3,7-bis-(4-trifluoromethylphenyl)-1,5,3,7-dioxadiazocane [MeSH Supplementary Concept]
- 3-(3-aminopropoxy)-1,5,9-triazacyclododecane [MeSH Supplementary Concept]
- 3-(3-aminopropyl)-1,5,9-triazacyclododecane [MeSH Supplementary Concept]
- 3-(N-(4-pyridino)carbamoyl)methyl-3,4,4-trimethyl-1,2-dioxetane [MeSH Supplementary Concept]
- 3-decyl-1,5,8-triazacyclodecane-2,4-dione [MeSH Supplementary Concept]
- 3-hydroxymethyl-3,4,4-trimethyl-1,2-dioxetane [MeSH Supplementary Concept]
- 3-vinyl-4H-1,2-dithiin [MeSH Supplementary Concept]
- 4,8,11-trimethyl-1,4,8,11-tetraazacyclotetradecane-1-acetate [MeSH Supplementary Concept]
- 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid [MeSH Supplementary Concept]
- 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- 4-bromoacetamidobenzyl-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- 4-hydroxymethyl-3,3,4-trimethyl-1,2-dioxetane [MeSH Supplementary Concept]
- 4-methoxyphenyl-1,3-dithiolane [MeSH Supplementary Concept]
- 4-n-dodecylphenyl compound [MeSH Supplementary Concept]
- 4-n-heptylphenyl compound [MeSH Supplementary Concept]
- 5,7,12,14-tetramethyldibenzo(b,i)(1,4,8,11)tetraazacyclotetradecahexenate [MeSH Supplementary Concept]
- 6-(4-bromoacetamidobenzyl)-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- 6-(4-methoxyphenyl)-2,4-diphenylverdazyl [MeSH Supplementary Concept]
- 6-(4-nitrophenyl)-2,4-diphenylverdazyl [MeSH Supplementary Concept]
- 6-methyl-8-methylsulfonyl-1,3,4,6-tetrahydro-2H-5,1-benzothiazocine [MeSH Supplementary Concept]
- 6pi-2-azatriene [MeSH Supplementary Concept]
- 7-((dimethylphenyl)silyl)-2-oxo-6-(2-phenylcyclohexyloxy)-2a,3,6,7,7a,7b-hexahydro-2H-1,4,5-trioxa-4a-azacyclopenta(cd)indene-3-carboxylic acid 1-methylethyl ester [MeSH Supplementary Concept]
- 9-benzyl-3-methylene-1,5-di-p-toluenesulfonyl-1,5,9-triazacyclododeane [MeSH Supplementary Concept]
- 9-methyl-8-phenyl-6-((2-phenylcyclohexyl)oxy)-4-aza-3,5-dioxatricyclo(5.2.1.0(4,9))decane [MeSH Supplementary Concept]
- 94-126 compound [MeSH Supplementary Concept]
- 95-588 compound [MeSH Supplementary Concept]
- 99-411 compound [MeSH Supplementary Concept]
- AR C117977 [MeSH Supplementary Concept]
- AS 186c [MeSH Supplementary Concept]
- AS 186d [MeSH Supplementary Concept]
- CT 77 [MeSH Supplementary Concept]
- CX157 [MeSH Supplementary Concept]
- Crismel [MeSH Supplementary Concept]
- DOTA-glycyl-glycyl-glycyl-(4-nitrophenyl)alanine amide [MeSH Supplementary Concept]
- FR 134043 [MeSH Supplementary Concept]
- FR177391 [MeSH Supplementary Concept]
- Gd-MCTA [MeSH Supplementary Concept]
- JM 2763 [MeSH Supplementary Concept]
- JSTX-3 [MeSH Supplementary Concept]
- LT-171-861 [MeSH Supplementary Concept]
- N',N',N'-tris(2-methyl-2-mercaptopropyl)-1,4,7-triazacyclononane [MeSH Supplementary Concept]
- N,N',N'',N'''-tetrakis(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane [MeSH Supplementary Concept]
- N,N',N''-tris(2-methyl-(2-mercaptopropyl))-1,4,7-triazacyclononane-pertechnetate [MeSH Supplementary Concept]
- N,N',N''-tris(2-methyl-(2-propanethiol))-1,4,7-triazacyclononane [MeSH Supplementary Concept]
- N-benzyl-3,11-azatricyclo(6.3.0.0(2,6))undecane [MeSH Supplementary Concept]
- N-nitrosodithiazine [MeSH Supplementary Concept]
- N-octyl-3,11-azatricyclo(6.3.0.0(2,6))undecane [MeSH Supplementary Concept]
- NSTX-3 [MeSH Supplementary Concept]
- RAP polymer [MeSH Supplementary Concept]
- RD3 0028 [MeSH Supplementary Concept]
- SBI-797812 [MeSH Supplementary Concept]
- SID 791 [MeSH Supplementary Concept]
- TD-2749 [MeSH Supplementary Concept]
- YM-96765 [MeSH Supplementary Concept]
- acutiphycin [MeSH Supplementary Concept]
- adroxazine [MeSH Supplementary Concept]
- alkaloid GB18 [MeSH Supplementary Concept]
- contrast agent P792 [MeSH Supplementary Concept]
- copper acetamidobenzyl-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-serum albumin [MeSH Supplementary Concept]
- copper(II)-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- copper-67-2IT-BAT-Lym-1 [MeSH Supplementary Concept]
- corrigendum compound [MeSH Supplementary Concept]
- cyclam [MeSH Supplementary Concept]
- cyclen [MeSH Supplementary Concept]
- deoxocarbaqinghaosu [MeSH Supplementary Concept]
- desoxymorellin [MeSH Supplementary Concept]
- deucravacitinib [MeSH Supplementary Concept]
- diamsar chelate [MeSH Supplementary Concept]
- dichloro(triazacyclononane)copper(II) [MeSH Supplementary Concept]
- dimethyldioxetanone [MeSH Supplementary Concept]
- dioxocyclam [MeSH Supplementary Concept]
- dithietane-1,3-dioxide [MeSH Supplementary Concept]
- enisamium iodide [MeSH Supplementary Concept]
- flufenzine [MeSH Supplementary Concept]
- flurenizid [MeSH Supplementary Concept]
- forbesione [MeSH Supplementary Concept]
- frankiamide [MeSH Supplementary Concept]
- gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate [MeSH Supplementary Concept]
- gadolinium Cy(2)DOTA [MeSH Supplementary Concept]
- gadolinium DOTA meglumine [MeSH Supplementary Concept]
- gadoteridol [MeSH Supplementary Concept]
- galbulimima alkaloid 13 [MeSH Supplementary Concept]
- gallium 1,4,7-triazacyclononane-N,N',N''-tris(methylenephosphonic acid) [MeSH Supplementary Concept]
- genivir [MeSH Supplementary Concept]
- hexanal-1,3-dithiane [MeSH Supplementary Concept]
- hexatroxanone [MeSH Supplementary Concept]
- himgaline [MeSH Supplementary Concept]
- hopromalinol [MeSH Supplementary Concept]
- hoprominol [MeSH Supplementary Concept]
- indium 111-DOTA-lanreotide [MeSH Supplementary Concept]
- indium-111-DOTA-peptide chimeric L6 [MeSH Supplementary Concept]
- kevloc [MeSH Supplementary Concept]
- lansamide-2 [MeSH Supplementary Concept]
- lead-203 DOTA-B72.3 [MeSH Supplementary Concept]
- lipogrammistin A [MeSH Supplementary Concept]
- macrocycle 1 [MeSH Supplementary Concept]
- macrosphelide A [MeSH Supplementary Concept]
- macrosphelide B [MeSH Supplementary Concept]
- mesulfen [MeSH Supplementary Concept]
- mustelan [MeSH Supplementary Concept]
- octahydro-9-hydroxyethyl-1-methoxy-3,4,4-trimethyl-1H-3,9a-peroxy-2-benzoxepin [MeSH Supplementary Concept]
- pentatroxane [MeSH Supplementary Concept]
- phenoxathiin [MeSH Supplementary Concept]
- plerixafor [MeSH Supplementary Concept]
- polylysine-(Gd-DOTA) [MeSH Supplementary Concept]
- pteriatoxin A [MeSH Supplementary Concept]
- pteriatoxin B [MeSH Supplementary Concept]
- pteriatoxin C [MeSH Supplementary Concept]
- pyrenophorol [MeSH Supplementary Concept]
- ro 48-3656 [MeSH Supplementary Concept]
- s-trioxane [MeSH Supplementary Concept]
- sar chelate [MeSH Supplementary Concept]
- sekothrixide [MeSH Supplementary Concept]
- setosol [MeSH Supplementary Concept]
- south 7 [MeSH Supplementary Concept]
- spirotenuipesine A [MeSH Supplementary Concept]
- spirotenuipesine B [MeSH Supplementary Concept]
- ternelin [MeSH Supplementary Concept]
- tetraaza(1.1.1.1)cyclophane [MeSH Supplementary Concept]
- tetraaza-14-crown-4 [MeSH Supplementary Concept]
- tetraformaltrisazine [MeSH Supplementary Concept]
- tetrathiafulvalene [MeSH Supplementary Concept]
- tetravinyl-tetramethylcyclo-tetrasiloxane [MeSH Supplementary Concept]
- thiahexatroxane [MeSH Supplementary Concept]
- thianthrene [MeSH Supplementary Concept]
- thiirancarboxylic acid [MeSH Supplementary Concept]
- treloxinate [MeSH Supplementary Concept]
- tris(o-phenylenedioxy)cyclotriphosphazene [MeSH Supplementary Concept]
- tulathromycin [MeSH Supplementary Concept]
- vermixocin A [MeSH Supplementary Concept]
- yttrium 90-DOTA-lanreotide [MeSH Supplementary Concept]
- yttrium(III)-1,4,7,10-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid [MeSH Supplementary Concept]
- yttrium-90-DOTA-peptide-chimeric L6 [MeSH Supplementary Concept]
- zinc xylyl-bicyclam [MeSH Supplementary Concept]
See also
- polycyclic compounds [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients